New York, NY -- (SBWIRE) -- 03/12/2018 -- Description:

This report studies the global Tumor Biomarker Test market, analyzes and researches the Tumor Biomarker Test development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3054798-global-tumor-biomarker-test-market-size-status-and-forecast-2025

For more information or any query mail at sales@wiseguyreports.com

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others

Market segment by Application, Tumor Biomarker Test can be split into
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer

Report Details @ https://www.wiseguyreports.com/reports/3054798-global-tumor-biomarker-test-market-size-status-and-forecast-2025

Table Of Contents – Major Key Points

Global Tumor Biomarker Test Market Size, Status and Forecast 2025
1 Industry Overview of Tumor Biomarker Test
1.1 Tumor Biomarker Test Market Overview
1.1.1 Tumor Biomarker Test Product Scope
1.1.2 Market Status and Outlook
1.2 Global Tumor Biomarker Test Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Tumor Biomarker Test Market by Type
1.3.1 Prostate Specific Antigen Tests
1.3.2 CTC Tests
1.3.3 Alpha-Fetoprotein (AFP) Tests
1.3.4 CA Test
1.3.5 HER2 Tests
1.3.6 BRCA Test
1.3.7 Anaplastic Lymphoma Kinase (ALK) Tests
1.3.8 EGFR Mutation Tests
1.3.9 KRAS Test
1.3.10 Others
1.4 Tumor Biomarker Test Market by End Users/Application
1.4.1 Lung cancer
1.4.2 Breast cancer
1.4.3 Colorectal
1.4.4 Prostate Cancer
1.4.5 Blood Cancer

2 Global Tumor Biomarker Test Competition Analysis by Players
2.1 Tumor Biomarker Test Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Abbott Laboratories, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Agilent Technologies
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 AstraZeneca
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Becton Dickinson & Co.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Biocept Inc.
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Cancer Genetics Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Danaher Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Foundation Medicine Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Illumina Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Tumor Biomarker Test Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments

Continue……

For more information or any query mail at sales@wiseguyreports.com

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.